BASF Group releases Q2 2025 preliminary figures and adjusts full-year 2025 outlook due to global economic uncertainties ...

Jungheinrich AG has announced it is in the final stages of negotiations to sell its Russian subsidiary, Jungheinrich Lift Truck OOO, to three financial investors. This decision marks Jungheinrich's ...

Nicox SA has announced the completion of the Denali Phase 3 clinical trial for NCX 470, involving 696 patients with open-angle glaucoma or ocular hypertension. The trial marks a significant ...

Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors. Re-election of Chairman and board members. Shareholders approved share capital reduction, dividend ...

The Goldman Sachs Group, Inc. announced that it has lowered its stake in Veolia Environnement's share capital and voting rights to 5%. As of June 17, 2025, Goldman Sachs held 4.94% of the share ...

Crédit Agricole Ille-et-Vilaine plans to issue €150 million in shares, offering customers the opportunity to become members. These shares, with a nominal value of €1.53, aim to expand the membership ...

Odyssée Technologies held its Ordinary General Meeting on June 26, 2025, in Les Premiers Sapins, France. The quorum was 81.16% of shareholders. All proposed resolutions were adopted unanimously, ...

Déclaration de franchissement de seuils par The Goldman Sachs Group, Inc. concernant NANOBIOTIX, une société cotée sur Euronext Paris ...

Inventiva, a biopharmaceutical company, has announced the appointment of Renée Aguiar-Lucander to its Board of Directors. The shareholders approved this addition during the company's recent Annual ...

The SMCP Combined Shareholders' Meeting took place on June 12th, 2025 in Paris, chaired by Christophe Cuvillier. A substantial 57.52% of the company's share capital participated. Shareholders approved ...

On June 3, 2025, The Goldman Sachs Group, Inc., announced by mail its increase in its stake in the capital and voting rights of SOITEC. The group crossed the 5% threshold on May 28, 2025, reaching ...

On June 25, 2025, Valneva SE, a specialty vaccine company, announced the successful outcome of its Annual General Meeting in Lyon, France. Shareholders approved all resolutions proposed by the Board ...